Article
Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes.
Diabetic medicine : a journal of the British Diabetic Association - 1 Apr 2016
Dujic T, Causevic A, Bego T, Malenica M, Velija-Asimi Z, Pearson E R, Semiz S
Abstract excerpt
AIMS: Metformin is the most widely used oral anti-diabetes agent and has considerable benefits over other therapies, yet 20-30% of people develop gastrointestinal side effects, and 5% are unable to tolerate metformin due to the severity of these side effects. The mechanism for gastrointestinal side effects and their considerable inter-individual variability is unclear. We have recently shown the association...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
